Pyxis Oncology, Inc. (PYXS)
2.03
+0.04
(+2.01%)
USD |
NASDAQ |
Oct 09, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Market Cap : 128.77M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 128.77M |
| October 08, 2026 | 126.24M |
| October 07, 2026 | 127.50M |
| October 06, 2026 | 128.14M |
| October 05, 2026 | 142.09M |
| October 02, 2026 | 135.75M |
| October 01, 2026 | 138.92M |
| September 30, 2026 | 147.80M |
| September 29, 2026 | 183.96M |
| September 28, 2026 | 183.96M |
| September 25, 2026 | 181.42M |
| September 24, 2026 | 185.23M |
| September 23, 2026 | 204.26M |
| September 22, 2026 | 212.82M |
| September 21, 2026 | 202.36M |
| September 18, 2026 | 211.24M |
| September 17, 2026 | 216.31M |
| September 16, 2026 | 211.87M |
| September 15, 2026 | 211.24M |
| September 14, 2026 | 217.58M |
| September 11, 2026 | 203.63M |
| September 10, 2026 | 207.43M |
| September 09, 2026 | 214.41M |
| September 08, 2026 | 246.76M |
| September 04, 2026 | 246.76M |
| Date | Value |
|---|---|
| September 03, 2026 | 226.15M |
| September 02, 2026 | 237.88M |
| September 01, 2026 | 218.22M |
| August 31, 2026 | 205.53M |
| August 28, 2026 | 204.89M |
| August 27, 2026 | 210.60M |
| August 26, 2026 | 211.87M |
| August 25, 2026 | 194.11M |
| August 24, 2026 | 187.77M |
| August 21, 2026 | 195.38M |
| August 20, 2026 | 197.92M |
| August 19, 2026 | 213.78M |
| August 18, 2026 | 189.67M |
| August 17, 2026 | 191.57M |
| August 14, 2026 | 190.94M |
| August 13, 2026 | 190.94M |
| August 12, 2026 | 201.72M |
| August 11, 2026 | 179.52M |
| August 10, 2026 | 242.96M |
| August 07, 2026 | 234.36M |
| August 06, 2026 | 235.62M |
| August 05, 2026 | 196.66M |
| August 04, 2026 | 198.55M |
| August 03, 2026 | 191.01M |
| July 31, 2026 | 166.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
| Vericel Corp. | 2.052B |
Market Cap Related Metrics
| PS Ratio | 11.62 |
| Price to Book Value | 11.26 |
| Price | 2.03 |
| Earnings Yield | -69.13% |